C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

Published Date: 15 Nov 2023

Oncotarget has released a new editorial perspective titled "C/EBP? cooperates with MYB to maintain the oncogenic program of AML cells.".

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The pandemic had little impact on mental health symptoms.

2.

a cutting-edge cancer diagnostic tool.

3.

Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

4.

Research has shown that Ga-68 FAPI PET enhances pancreatic cancer detection and staging.

5.

How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot